Ireland’s economic success is due in no small part to the life sciences sector, but the challenge now is how to maintain a ...

Three-quarters of pharma and life sciences executives said they were optimistic for 2025, even though they expect some level ...

According to multiple websites that track grey market activities, Sai Life Sciences’s shares are commanding a premium of Rs ...

Many VCs, particularly newer firms, readily admit that 2024 has been a challenging year for raising fresh capital. Dimension ...

Valuations of life sciences businesses declined in the wake of the global pandemic, but government stimulus and medical ...

In an exclusive interview, an expert in Unispace's Life Sciences growth strategy across the Americas, offers his perspective ...

Sai Life Sciences' IPO saw an 84% subscription rate on its first day. Institutional investors showed strong interest. The IPO ...

The public issue of Sai Life Sciences kept its positive momentum on Day 2 of its subscription as well and saw 90% subscription so far on December 12 with qualified institutional buyers or QIBs showing ...

At the end of the first day of the bidding process, Sai Life Sciences IPO was subscribed 84%, led by strong demand from ...

Network Rail is looking at a “transformational” life sciences-led redevelopment of London’s Euston station as part of a £15bn ...

Retail investors subscribed 8%, non-institutional investors 4%, while qualified institutional buyers made no bids yet for the ...

The proposed initial public offering includes a new issuance of equity shares amounting to ₹ 950 crore, along with an offer ...